| Biomarker ID | 1239 |
| PMID | 24189640 |
| Year | 2014 |
| Biomarker | cutaneous fatty acid-binding protein (C-FABP) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Low Vs Moderate Vs High Gleason Score |
| Type of Biomarker | Prognostic |
| Cohort | 35 patients with Benign Prostatic Hyperplasia, and 97 prostate adenocarinomas were chosen for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | arcinomas were divided into low (≤5), moderate (6-7) and high (8-10) Gleason Score groups |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Human Patient Cohort |
| Technical Name | NA |